|
1
|
Yamashita T, Ishida M, Moro H, Yumoto H,
Uchibayashi S, Yoshii M, Nakanishi R, Okuno H, Yoshida T, Okuno T,
et al: Primary bone marrow diffuse large B-cell lymphoma
accompanying cold agglutinin disease: A case report with review of
the literature. Oncol Lett. 7:79–81. 2014.PubMed/NCBI
|
|
2
|
Morice WG, Rodriguez FJ, Hoyer JD and
Kurtin PJ: Diffuse large B-cell lymphoma with distinctive patterns
of splenic and bone marrow involvement: Clinicopathologic features
of two cases. Mod Pathol. 18:495–502. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Mann RB: Are there site-specific
differences among extranodal aggressive B-cell neoplasms? Am J Clin
Pathol. 111(1 Suppl 1): S144–S150. 1999.PubMed/NCBI
|
|
4
|
Lapa C, Knott M, Rasche L, Herrmann K,
Buck AK and Rosenwald A: Primary bone marrow diffuse large B-cell
lymphoma affecting distal parts of the legs as a cause of
persisting B symptoms. Eur J Haematol. 93:545–546. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Ogura K, Miyake N, Yasuda H, Udaka N and
Hirano T: Diffuse large B-cell lymphoma initially manifesting in
bone marrow: A case report. Rinsho Byori. 58:1176–1180. 2010.(In
Japanese). PubMed/NCBI
|
|
6
|
Antic D, Petrovic N, Pelemis M, Stevanovic
G, Perunicic M and Mihaljevic B: ‘Invisible’ primary cutaneous
diffuse large B-Cell lymphoma, leg type, as a cause of fever of
unknown origin. J Clin Oncol. 31:e276–e279. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Martinez A, Ponzoni M, Agostinelli C,
Hebeda KM, Matutes E, Peccatori J, Campidelli C, Espinet B, Perea
G, Acevedo A, et al: Primary bone marrow lymphoma: An uncommon
extranodal presentation of aggressive non-Hodgkin lymphomas. Am J
Surg Pathol. 36:296–304. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Jiang AG, Gao XY and Lu HY: Diagnosis and
management of a patient with primary pulmonary diffuse large B-cell
lymphoma: A case report and review of the literature. Exp Ther Med.
8:797–800. 2014.PubMed/NCBI
|
|
9
|
Menon MP, Pittaluga S and Jaffe ES: The
histological and biological spectrum of diffuse large B-cell
lymphoma in the World Health Organization classification. Cancer J.
18:411–420. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Oehler E, Valour F, Hachulla E and Ghawche
F: Myopericarditis as the presenting manifestation of adult Still's
disease. Rev Med Interne. 35:827–830. 2014.(In French). View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Imamura K, Awaki E, Aoyama Y, Kondo S,
Horie Y, Ohama E and Nakashima K: Intravascular large B-cell
lymphoma following a relapsing stroke with temporary fever: A brain
biopsy case. Intern Med. 45:693–695. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Lokesh KN, Sathyanarayanan V,
Kuntegowdanahalli CL, Suresh TM, Dasappa L and Kanakasetty GB:
Primary diffuse large B-cell lymphoma of testis: A single centre
experience and review of literature. Urol Ann. 6:231–234. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Kashimura M, Noro M, Akikusa B, Okuhara A,
Momose S, Miura I, Kojima M and Tamaru J: Primary splenic diffuse
large B-cell lymphoma manifesting in red pulp. Virchows Arch.
453:501–509. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Kim HS: Primary testicular diffuse large
B-cell lymphoma: A case report focusing on touch imprint cytology
and a non-germinal center B-cell-like phenotype. Exp Ther Med.
6:33–36. 2013.PubMed/NCBI
|
|
15
|
Zhang X, Sun M, Zhang L and Shao H:
Primary hepatosplenic CD5-positive diffuse large B-cell lymphoma: A
case report with literature review. Int J Clin Exp Pathol.
6:985–989. 2013.PubMed/NCBI
|
|
16
|
Kodama K, Massone C, Chott A, Metze D,
Kerl H and Cerroni L: Primary cutaneous large B-cell lymphomas:
Clinicopathologic features, classification, and prognostic factors
in a large series of patients. Blood. 106:2491–2497. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Al Shemmari S, Sankaranarayanan SP and
Krishnan Y: Primary mediastinal large B-cell lymphoma: Clinical
features, prognostic factors and survival with RCHOP in Arab
patients in the PET scan era. Lung India. 31:228–231. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Níáinle F, Hamnvik OP, Gulmann C,
Bermingham C, Kelly J, McEvoy P and Murphy P: Diffuse large B-cell
lymphoma with isolated bone marrow involvement presenting with
secondary cold agglutinin disease. Int J Lab Hematol. 30:444–445.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Kajiura D, Yamashita Y and Mori N: Diffuse
large B-cell lymphoma initially manifesting in the bone marrow. Am
J Clin Pathol. 127:762–769. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Chang H, Hung YS, Lin TL, Wang PN, Kuo MC,
Tang TC, Wu JH, Dunn P and Shih LY: Primary bone marrow diffuse
large B cell lymphoma: A case series and review. Ann Hematol.
90:791–796. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Sumi M, Ichikawa N, Shimizu I, Yotsumoto
M, Ueno M and Kobayashi H: Primary diffuse large B-cell lymphoma of
the bone marrow complicated with autoimmune hemolytic anemia and
erythroid hypoplasia. Rinsho Ketsueki. 48:571–575. 2007.(In
Japanese). PubMed/NCBI
|
|
22
|
Hishizawa M, Okamoto K, Chonabayashi K,
Kaneko H, Watanabe M and Tsudo M: Primary large B-cell lymphoma of
the bone marrow. Br J Haematol. 136:3512007. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Wong KF, Chan JK, Ng CS, Chu YC, Li LP and
Chan CH: Large cell lymphoma with initial presentation in the bone
marrow. Hematol Oncol. 10:261–271. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Jerusalem G, Beguin Y, Fassotte MF, Najjar
F, Paulus P, Rigo P and Fillet G: Whole-body positron emission
tomography using 18F-fluorodeoxyglucose for posttreatment
evaluation in Hodgkin's disease and non-Hodgkin's lymphoma has
higher diagnostic and prognostic value than classical computed
tomography scan imaging. Blood. 94:429–433. 1999.PubMed/NCBI
|
|
25
|
Zinzani PL, Fanti S, Battista G, Tani M,
Castellucci P, Stefoni V, Alinari L, Farsad M, Musuraca G, Gabriele
A, et al: Predictive role of positron emission tomography (PET) in
the outcome of lymphoma patients. Br J Cancer. 91:850–854.
2004.PubMed/NCBI
|
|
26
|
Tai WM, Quah D, Yap SP, Tan SH, Tang T,
Tay KW, Koo YX, Tao M, Quek R and Lim ST: Primary mediastinal large
B-cell lymphoma: Optimal therapy and prognostic factors in 41
consecutive Asian patients. Leuk Lymphoma. 52:604–612. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Avilés A, Neri N, Fernández R,
Huerta-Guzmán J and Nambo MJ: Randomized clinical trial to assess
the efficacy of radiotherapy in primary mediastinal large
B-lymphoma. Int J Radiat Oncol Biol Phys. 83:1227–1231. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zhu YJ, Huang JJ, Xia Y, Zhao W, Jiang WQ,
Lin TY, Huang HQ and Li ZM: Primary mediastinal large B-cell
lymphoma (PMLBCL) in Chinese patients: Clinical characteristics and
prognostic factors. Int J Hematol. 94:178–184. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Niscola P, Palombi M, Fratoni S, Perrotti
A and de Fabritiis P: Primary diffuse large B-cell lymphoma of the
bone marrow in a frail and elderly patient successfully treated
with rituximab, cyclophosphamide, doxorubicin, vincristine, and
prednisone. Blood Res. 48:296–297. 2013. View Article : Google Scholar : PubMed/NCBI
|
